Real World Use of Afatinib in NSCLC EGFRm plus Patients Outside Clinical Trials: A FAETT Experience

dc.contributor.authorRamos Garcia, I.
dc.contributor.authorSanchez, A.
dc.contributor.authorOrtega, A. L.
dc.contributor.authorPradera, J.
dc.contributor.authorCobo, M.
dc.contributor.authorMoreno, M. A.
dc.contributor.authorBarneto, I.
dc.contributor.authorRuiz, S.
dc.contributor.authorFernandez, I.
dc.contributor.authorGarcia, T.
dc.contributor.authorToscano, F.
dc.contributor.authorTrigo Perez, J. M.
dc.contributor.authoraffiliation[Ramos Garcia, I.] Hosp Univ Virgen de La Victoria, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Ruiz, S.] Hosp Univ Virgen de La Victoria, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Sanchez, A.] Hosp Virgen Del Rocio, Seville, Spain
dc.contributor.authoraffiliation[Ortega, A. L.] Complejo Hosp Jaen, Jaen, Spain
dc.contributor.authoraffiliation[Pradera, J.] Hosp Virgen de Valme, Seville, Spain
dc.contributor.authoraffiliation[Cobo, M.] Univ Hosp Reg Malaga, Ibima, Malaga, Spain
dc.contributor.authoraffiliation[Moreno, M. A.] Hosp Univ Puerto Real, Cadiz, Spain
dc.contributor.authoraffiliation[Barneto, I.] Hosp Univ Reina Sofia, Cordoba, Spain
dc.contributor.authoraffiliation[Fernandez, I.] Hosp Univ Jerez, Jerez de la Frontera, Spain
dc.contributor.authoraffiliation[Garcia, T.] Hosp Virgen de La Macarena, Seville, Spain
dc.contributor.authoraffiliation[Toscano, F.] Hosp Juan Ramon Jimenez, Huelva, Spain
dc.contributor.authoraffiliation[Trigo Perez, J. M.] Hosp Virgen de La Victoria, Malaga, Spain
dc.date.accessioned2025-01-07T13:03:07Z
dc.date.available2025-01-07T13:03:07Z
dc.date.issued2019-10-01
dc.identifier.doi10.1016/j.jtho.2019.08.2001
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S155608641932684X/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25166
dc.identifier.wosID492162205052
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Puerto Real
dc.organizationSAS - Hospital Universitario de Jerez de la Frontera
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Juan Ramón Jiménez
dc.organizationSAS - Hospital Universitario de Jaén
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.organizationSAS - Hospital Universitario Virgen de Valme
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS921-S922
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectOlder EGFRm plus NSCLC
dc.titleReal World Use of Afatinib in NSCLC EGFRm plus Patients Outside Clinical Trials: A FAETT Experience
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number14
dc.wostypeMeeting Abstract

Files